Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO32846 | heamatoxylon campechianum | Species | NA | NA | Stems | XiShuangBanNa, Yunnan Province, China | 2005-SEP |
PMID[18610999] |
NPO29935 | Caesalpinia sappan | Species | Fabaceae | Eukaryota |
PMID[23234407] |
|||
NPO2554 | Biancaea sappan | Species | Fabaceae | Eukaryota | TM-MC* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT1 | Others | Radical scavenging activity | IC50 | = | 35000 | nM | 17967537 | |
NPT632 | Tissue | Brain | Rattus norvegicus | IC50 | = | 14330 | nM | 17967537 |
NPT2 | Others | Unspecified | Activity | = | 49.3 | 17967537 | ||
NPT36 | Individual Protein | Tyrosine-protein kinase SRC | Homo sapiens | Inhibition | = | 7.7 | % | 18610999 |
NPT1478 | Individual Protein | Vascular endothelial growth factor receptor 2 | Homo sapiens | Inhibition | = | 52 | % | 18610999 |
NPT1479 | Individual Protein | Stem cell growth factor receptor | Homo sapiens | Inhibition | = | 17.5 | % | 18610999 |
NPT285 | Individual Protein | Epidermal growth factor receptor erbB1 | Homo sapiens | Inhibition | = | 6.4 | % | 18610999 |
NPT1480 | Individual Protein | Fibroblast growth factor receptor 1 | Homo sapiens | Inhibition | = | 69.5 | % | 18610999 |
NPT1481 | Individual Protein | Fibroblast growth factor receptor 2 | Homo sapiens | Inhibition | = | 17.7 | % | 18610999 |
NPT1337 | Individual Protein | Hepatocyte growth factor receptor | Homo sapiens | Inhibition | = | 56.6 | % | 18610999 |
NPT35 | Others | n.a. | IC50 | = | 96580 | nM | 23234407 | |
NPT113 | Cell Line | RAW264.7 | Mus musculus | IC50 | = | 8300 | nM | 23234407 |
NPT113 | Cell Line | RAW264.7 | Mus musculus | IC50 | = | 5700 | nM | 23234407 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC95864 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9859 | High Similarity | NPC105512 |
0.9789 | High Similarity | NPC3036 |
0.9722 | High Similarity | NPC31363 |
0.972 | High Similarity | NPC1612 |
0.972 | High Similarity | NPC183959 |
0.9655 | High Similarity | NPC257648 |
0.9655 | High Similarity | NPC477231 |
0.965 | High Similarity | NPC119059 |
0.965 | High Similarity | NPC188679 |
0.965 | High Similarity | NPC321011 |
0.965 | High Similarity | NPC294852 |
0.9589 | High Similarity | NPC141212 |
0.9589 | High Similarity | NPC469550 |
0.958 | High Similarity | NPC108406 |
0.9577 | High Similarity | NPC70136 |
0.9524 | High Similarity | NPC2928 |
0.9521 | High Similarity | NPC219582 |
0.9521 | High Similarity | NPC302950 |
0.9521 | High Similarity | NPC236637 |
0.9521 | High Similarity | NPC472912 |
0.9521 | High Similarity | NPC260979 |
0.9517 | High Similarity | NPC29231 |
0.9514 | High Similarity | NPC196277 |
0.9514 | High Similarity | NPC272721 |
0.9514 | High Similarity | NPC43669 |
0.9507 | High Similarity | NPC242893 |
0.9507 | High Similarity | NPC279121 |
0.9507 | High Similarity | NPC38065 |
0.9504 | High Similarity | NPC301178 |
0.9504 | High Similarity | NPC284556 |
0.9459 | High Similarity | NPC472916 |
0.9459 | High Similarity | NPC474638 |
0.9456 | High Similarity | NPC213896 |
0.9456 | High Similarity | NPC256346 |
0.9456 | High Similarity | NPC192083 |
0.9456 | High Similarity | NPC325028 |
0.9456 | High Similarity | NPC27532 |
0.9456 | High Similarity | NPC246328 |
0.9456 | High Similarity | NPC18727 |
0.9452 | High Similarity | NPC260895 |
0.9452 | High Similarity | NPC204515 |
0.9448 | High Similarity | NPC52005 |
0.9448 | High Similarity | NPC87125 |
0.9448 | High Similarity | NPC183950 |
0.9448 | High Similarity | NPC270465 |
0.9448 | High Similarity | NPC137062 |
0.9448 | High Similarity | NPC287101 |
0.9448 | High Similarity | NPC223579 |
0.9444 | High Similarity | NPC74881 |
0.9444 | High Similarity | NPC51443 |
0.9444 | High Similarity | NPC168803 |
0.9444 | High Similarity | NPC77378 |
0.9437 | High Similarity | NPC471417 |
0.9437 | High Similarity | NPC175013 |
0.9396 | High Similarity | NPC299520 |
0.9396 | High Similarity | NPC52530 |
0.9396 | High Similarity | NPC291508 |
0.9396 | High Similarity | NPC67876 |
0.9396 | High Similarity | NPC129684 |
0.9396 | High Similarity | NPC210084 |
0.9396 | High Similarity | NPC99597 |
0.9392 | High Similarity | NPC168247 |
0.9392 | High Similarity | NPC321779 |
0.9392 | High Similarity | NPC152951 |
0.9392 | High Similarity | NPC117992 |
0.9392 | High Similarity | NPC230149 |
0.9392 | High Similarity | NPC67396 |
0.9392 | High Similarity | NPC57674 |
0.9388 | High Similarity | NPC39732 |
0.9388 | High Similarity | NPC260491 |
0.9388 | High Similarity | NPC60972 |
0.9388 | High Similarity | NPC106976 |
0.9388 | High Similarity | NPC240476 |
0.9388 | High Similarity | NPC55205 |
0.9388 | High Similarity | NPC36835 |
0.9388 | High Similarity | NPC61506 |
0.9388 | High Similarity | NPC246162 |
0.9388 | High Similarity | NPC9743 |
0.9384 | High Similarity | NPC149127 |
0.9384 | High Similarity | NPC286342 |
0.9384 | High Similarity | NPC184136 |
0.9384 | High Similarity | NPC188871 |
0.9384 | High Similarity | NPC62042 |
0.9379 | High Similarity | NPC12367 |
0.9379 | High Similarity | NPC118726 |
0.9379 | High Similarity | NPC276930 |
0.9379 | High Similarity | NPC203747 |
0.9379 | High Similarity | NPC194653 |
0.9379 | High Similarity | NPC139364 |
0.9379 | High Similarity | NPC80710 |
0.9379 | High Similarity | NPC120464 |
0.9379 | High Similarity | NPC254702 |
0.9379 | High Similarity | NPC194856 |
0.9375 | High Similarity | NPC179271 |
0.9375 | High Similarity | NPC20791 |
0.9357 | High Similarity | NPC275055 |
0.9357 | High Similarity | NPC290291 |
0.9333 | High Similarity | NPC55738 |
0.9329 | High Similarity | NPC320825 |
0.9329 | High Similarity | NPC235165 |
0.9329 | High Similarity | NPC195796 |
0.9329 | High Similarity | NPC170026 |
0.9329 | High Similarity | NPC35038 |
0.9329 | High Similarity | NPC13858 |
0.9329 | High Similarity | NPC471500 |
0.9329 | High Similarity | NPC278778 |
0.9329 | High Similarity | NPC291878 |
0.9329 | High Similarity | NPC326037 |
0.9329 | High Similarity | NPC255106 |
0.9329 | High Similarity | NPC282307 |
0.9329 | High Similarity | NPC24640 |
0.9324 | High Similarity | NPC206238 |
0.9324 | High Similarity | NPC273462 |
0.9324 | High Similarity | NPC292214 |
0.9324 | High Similarity | NPC74924 |
0.9324 | High Similarity | NPC298692 |
0.9324 | High Similarity | NPC33051 |
0.9324 | High Similarity | NPC472915 |
0.9324 | High Similarity | NPC167091 |
0.9324 | High Similarity | NPC227337 |
0.9324 | High Similarity | NPC49402 |
0.9324 | High Similarity | NPC271779 |
0.9324 | High Similarity | NPC70433 |
0.9324 | High Similarity | NPC88645 |
0.932 | High Similarity | NPC125062 |
0.932 | High Similarity | NPC252933 |
0.932 | High Similarity | NPC200740 |
0.932 | High Similarity | NPC154345 |
0.932 | High Similarity | NPC251110 |
0.932 | High Similarity | NPC54394 |
0.9315 | High Similarity | NPC48479 |
0.9315 | High Similarity | NPC139293 |
0.9315 | High Similarity | NPC195763 |
0.9315 | High Similarity | NPC264550 |
0.9315 | High Similarity | NPC69430 |
0.9315 | High Similarity | NPC264289 |
0.9315 | High Similarity | NPC177298 |
0.9315 | High Similarity | NPC333691 |
0.9315 | High Similarity | NPC142876 |
0.9315 | High Similarity | NPC200060 |
0.9315 | High Similarity | NPC38545 |
0.9315 | High Similarity | NPC171916 |
0.9315 | High Similarity | NPC40290 |
0.931 | High Similarity | NPC140840 |
0.931 | High Similarity | NPC86847 |
0.931 | High Similarity | NPC207729 |
0.931 | High Similarity | NPC275772 |
0.931 | High Similarity | NPC130230 |
0.931 | High Similarity | NPC125449 |
0.931 | High Similarity | NPC239312 |
0.931 | High Similarity | NPC12200 |
0.931 | High Similarity | NPC188074 |
0.9301 | High Similarity | NPC287722 |
0.9301 | High Similarity | NPC254659 |
0.9291 | High Similarity | NPC99333 |
0.9291 | High Similarity | NPC280284 |
0.9291 | High Similarity | NPC188947 |
0.9272 | High Similarity | NPC474960 |
0.9267 | High Similarity | NPC162869 |
0.9267 | High Similarity | NPC472911 |
0.9267 | High Similarity | NPC471209 |
0.9267 | High Similarity | NPC96167 |
0.9267 | High Similarity | NPC472914 |
0.9267 | High Similarity | NPC472913 |
0.9267 | High Similarity | NPC471479 |
0.9267 | High Similarity | NPC474208 |
0.9267 | High Similarity | NPC472598 |
0.9267 | High Similarity | NPC156057 |
0.9267 | High Similarity | NPC472963 |
0.9267 | High Similarity | NPC222814 |
0.9267 | High Similarity | NPC475267 |
0.9267 | High Similarity | NPC474836 |
0.9267 | High Similarity | NPC472910 |
0.9267 | High Similarity | NPC48208 |
0.9267 | High Similarity | NPC245758 |
0.9267 | High Similarity | NPC52889 |
0.9267 | High Similarity | NPC474055 |
0.9267 | High Similarity | NPC27337 |
0.9267 | High Similarity | NPC471515 |
0.9262 | High Similarity | NPC470327 |
0.9262 | High Similarity | NPC255807 |
0.9262 | High Similarity | NPC213622 |
0.9262 | High Similarity | NPC477503 |
0.9262 | High Similarity | NPC45849 |
0.9262 | High Similarity | NPC200761 |
0.9262 | High Similarity | NPC256925 |
0.9262 | High Similarity | NPC256612 |
0.9262 | High Similarity | NPC20830 |
0.9262 | High Similarity | NPC31018 |
0.9262 | High Similarity | NPC234255 |
0.9262 | High Similarity | NPC113906 |
0.9257 | High Similarity | NPC212678 |
0.9257 | High Similarity | NPC100887 |
0.9257 | High Similarity | NPC275836 |
0.9257 | High Similarity | NPC301323 |
0.9257 | High Similarity | NPC239128 |
0.9257 | High Similarity | NPC25270 |
0.9257 | High Similarity | NPC83508 |
0.9257 | High Similarity | NPC156222 |
0.9257 | High Similarity | NPC180234 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC95864 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9521 | High Similarity | NPD1934 | Approved |
0.9507 | High Similarity | NPD1511 | Approved |
0.9456 | High Similarity | NPD2393 | Clinical (unspecified phase) |
0.9375 | High Similarity | NPD1512 | Approved |
0.92 | High Similarity | NPD3882 | Suspended |
0.9195 | High Similarity | NPD2801 | Approved |
0.9155 | High Similarity | NPD1549 | Phase 2 |
0.9085 | High Similarity | NPD1550 | Clinical (unspecified phase) |
0.9085 | High Similarity | NPD1552 | Clinical (unspecified phase) |
0.8944 | High Similarity | NPD1510 | Phase 2 |
0.891 | High Similarity | NPD6166 | Phase 2 |
0.891 | High Similarity | NPD6168 | Clinical (unspecified phase) |
0.891 | High Similarity | NPD6167 | Clinical (unspecified phase) |
0.8824 | High Similarity | NPD4868 | Clinical (unspecified phase) |
0.8797 | High Similarity | NPD3818 | Discontinued |
0.8758 | High Similarity | NPD3817 | Phase 2 |
0.8742 | High Similarity | NPD4380 | Phase 2 |
0.8742 | High Similarity | NPD7054 | Approved |
0.8688 | High Similarity | NPD7074 | Phase 3 |
0.8688 | High Similarity | NPD7472 | Approved |
0.8662 | High Similarity | NPD943 | Approved |
0.8662 | High Similarity | NPD1240 | Approved |
0.8658 | High Similarity | NPD4378 | Clinical (unspecified phase) |
0.8645 | High Similarity | NPD7075 | Discontinued |
0.8645 | High Similarity | NPD4381 | Clinical (unspecified phase) |
0.8634 | High Similarity | NPD6797 | Phase 2 |
0.8621 | High Similarity | NPD2796 | Approved |
0.8591 | High Similarity | NPD6799 | Approved |
0.858 | High Similarity | NPD7251 | Discontinued |
0.8571 | High Similarity | NPD7819 | Suspended |
0.8571 | High Similarity | NPD7096 | Clinical (unspecified phase) |
0.8542 | High Similarity | NPD1607 | Approved |
0.8528 | High Similarity | NPD4338 | Clinical (unspecified phase) |
0.8442 | Intermediate Similarity | NPD7411 | Suspended |
0.8418 | Intermediate Similarity | NPD5494 | Approved |
0.8415 | Intermediate Similarity | NPD7808 | Phase 3 |
0.8411 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.8397 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.8367 | Intermediate Similarity | NPD1551 | Phase 2 |
0.8333 | Intermediate Similarity | NPD1465 | Phase 2 |
0.8293 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.8276 | Intermediate Similarity | NPD1613 | Approved |
0.8276 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.8269 | Intermediate Similarity | NPD6801 | Discontinued |
0.8267 | Intermediate Similarity | NPD3750 | Approved |
0.8258 | Intermediate Similarity | NPD6599 | Discontinued |
0.8255 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.8252 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.8219 | Intermediate Similarity | NPD230 | Phase 1 |
0.8182 | Intermediate Similarity | NPD5403 | Approved |
0.8182 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.8176 | Intermediate Similarity | NPD3749 | Approved |
0.817 | Intermediate Similarity | NPD5401 | Approved |
0.8165 | Intermediate Similarity | NPD5402 | Approved |
0.8137 | Intermediate Similarity | NPD6959 | Discontinued |
0.8098 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.8086 | Intermediate Similarity | NPD6232 | Discontinued |
0.8061 | Intermediate Similarity | NPD5844 | Phase 1 |
0.8061 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.8054 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.8049 | Intermediate Similarity | NPD7473 | Discontinued |
0.8024 | Intermediate Similarity | NPD6559 | Discontinued |
0.8014 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.8012 | Intermediate Similarity | NPD919 | Approved |
0.8 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7961 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7933 | Intermediate Similarity | NPD3748 | Approved |
0.7927 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7917 | Intermediate Similarity | NPD1203 | Approved |
0.7914 | Intermediate Similarity | NPD1247 | Approved |
0.7908 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.7887 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.7881 | Intermediate Similarity | NPD2935 | Discontinued |
0.7852 | Intermediate Similarity | NPD447 | Suspended |
0.7852 | Intermediate Similarity | NPD1933 | Approved |
0.7843 | Intermediate Similarity | NPD2800 | Approved |
0.7834 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7829 | Intermediate Similarity | NPD2344 | Approved |
0.7808 | Intermediate Similarity | NPD9494 | Approved |
0.7806 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.7792 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7784 | Intermediate Similarity | NPD3751 | Discontinued |
0.7763 | Intermediate Similarity | NPD6099 | Approved |
0.7763 | Intermediate Similarity | NPD6100 | Approved |
0.7762 | Intermediate Similarity | NPD1610 | Phase 2 |
0.773 | Intermediate Similarity | NPD1548 | Phase 1 |
0.7727 | Intermediate Similarity | NPD1243 | Approved |
0.7722 | Intermediate Similarity | NPD920 | Approved |
0.7707 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7707 | Intermediate Similarity | NPD2533 | Approved |
0.7707 | Intermediate Similarity | NPD2534 | Approved |
0.7707 | Intermediate Similarity | NPD2532 | Approved |
0.7703 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7697 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.7673 | Intermediate Similarity | NPD1653 | Approved |
0.7655 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7651 | Intermediate Similarity | NPD2313 | Discontinued |
0.7647 | Intermediate Similarity | NPD5953 | Discontinued |
0.7635 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7635 | Intermediate Similarity | NPD6832 | Phase 2 |
0.7628 | Intermediate Similarity | NPD2309 | Approved |
0.7628 | Intermediate Similarity | NPD6190 | Approved |
0.7625 | Intermediate Similarity | NPD3226 | Approved |
0.7616 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7611 | Intermediate Similarity | NPD7501 | Clinical (unspecified phase) |
0.7597 | Intermediate Similarity | NPD2346 | Discontinued |
0.759 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7586 | Intermediate Similarity | NPD9269 | Phase 2 |
0.7586 | Intermediate Similarity | NPD9717 | Approved |
0.7582 | Intermediate Similarity | NPD2799 | Discontinued |
0.7566 | Intermediate Similarity | NPD6651 | Approved |
0.7564 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7558 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.7545 | Intermediate Similarity | NPD3787 | Discontinued |
0.7533 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.7532 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7529 | Intermediate Similarity | NPD7286 | Phase 2 |
0.75 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7484 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7417 | Intermediate Similarity | NPD411 | Approved |
0.7401 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.7397 | Intermediate Similarity | NPD422 | Phase 1 |
0.7383 | Intermediate Similarity | NPD2798 | Approved |
0.7365 | Intermediate Similarity | NPD6234 | Discontinued |
0.7365 | Intermediate Similarity | NPD3225 | Approved |
0.7361 | Intermediate Similarity | NPD9545 | Approved |
0.7355 | Intermediate Similarity | NPD7033 | Discontinued |
0.7355 | Intermediate Similarity | NPD4308 | Phase 3 |
0.7347 | Intermediate Similarity | NPD1608 | Approved |
0.733 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.7318 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.7315 | Intermediate Similarity | NPD1470 | Approved |
0.7314 | Intermediate Similarity | NPD8312 | Approved |
0.7314 | Intermediate Similarity | NPD8313 | Approved |
0.7312 | Intermediate Similarity | NPD7390 | Discontinued |
0.731 | Intermediate Similarity | NPD9268 | Approved |
0.7303 | Intermediate Similarity | NPD3268 | Approved |
0.7301 | Intermediate Similarity | NPD5808 | Clinical (unspecified phase) |
0.7299 | Intermediate Similarity | NPD7685 | Pre-registration |
0.7289 | Intermediate Similarity | NPD4288 | Approved |
0.7279 | Intermediate Similarity | NPD1201 | Approved |
0.7278 | Intermediate Similarity | NPD2654 | Approved |
0.7273 | Intermediate Similarity | NPD6844 | Discontinued |
0.7254 | Intermediate Similarity | NPD1241 | Discontinued |
0.7253 | Intermediate Similarity | NPD8090 | Clinical (unspecified phase) |
0.7238 | Intermediate Similarity | NPD4360 | Phase 2 |
0.7238 | Intermediate Similarity | NPD4363 | Phase 3 |
0.7237 | Intermediate Similarity | NPD4625 | Phase 3 |
0.7235 | Intermediate Similarity | NPD5710 | Approved |
0.7235 | Intermediate Similarity | NPD5711 | Approved |
0.7222 | Intermediate Similarity | NPD9493 | Approved |
0.7219 | Intermediate Similarity | NPD2861 | Phase 2 |
0.7207 | Intermediate Similarity | NPD4287 | Approved |
0.72 | Intermediate Similarity | NPD2797 | Approved |
0.7193 | Intermediate Similarity | NPD5242 | Approved |
0.719 | Intermediate Similarity | NPD3764 | Approved |
0.719 | Intermediate Similarity | NPD6798 | Discontinued |
0.7186 | Intermediate Similarity | NPD5353 | Approved |
0.7181 | Intermediate Similarity | NPD4749 | Approved |
0.7172 | Intermediate Similarity | NPD5536 | Phase 2 |
0.7169 | Intermediate Similarity | NPD37 | Approved |
0.7168 | Intermediate Similarity | NPD7228 | Approved |
0.716 | Intermediate Similarity | NPD7422 | Clinical (unspecified phase) |
0.7152 | Intermediate Similarity | NPD7266 | Discontinued |
0.7152 | Intermediate Similarity | NPD1019 | Discontinued |
0.7143 | Intermediate Similarity | NPD17 | Approved |
0.7143 | Intermediate Similarity | NPD4966 | Approved |
0.7143 | Intermediate Similarity | NPD5019 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD4965 | Approved |
0.7143 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7114 | Intermediate Similarity | NPD3972 | Approved |
0.7108 | Intermediate Similarity | NPD7615 | Clinical (unspecified phase) |
0.7108 | Intermediate Similarity | NPD6386 | Approved |
0.7108 | Intermediate Similarity | NPD6385 | Approved |
0.7105 | Intermediate Similarity | NPD3018 | Phase 2 |
0.7104 | Intermediate Similarity | NPD4361 | Phase 2 |
0.7104 | Intermediate Similarity | NPD4362 | Clinical (unspecified phase) |
0.7102 | Intermediate Similarity | NPD6104 | Discontinued |
0.7101 | Intermediate Similarity | NPD6971 | Discontinued |
0.7099 | Intermediate Similarity | NPD4357 | Discontinued |
0.7097 | Intermediate Similarity | NPD4307 | Phase 2 |
0.7095 | Intermediate Similarity | NPD8434 | Phase 2 |
0.7091 | Intermediate Similarity | NPD7458 | Discontinued |
0.709 | Intermediate Similarity | NPD7584 | Approved |
0.7089 | Intermediate Similarity | NPD5405 | Approved |
0.7089 | Intermediate Similarity | NPD5404 | Approved |
0.7089 | Intermediate Similarity | NPD5408 | Approved |
0.7089 | Intermediate Similarity | NPD5406 | Approved |
0.7086 | Intermediate Similarity | NPD1729 | Discontinued |
0.7086 | Intermediate Similarity | NPD3266 | Approved |
0.7086 | Intermediate Similarity | NPD3267 | Approved |
0.7083 | Intermediate Similarity | NPD2296 | Approved |
0.7081 | Intermediate Similarity | NPD2354 | Approved |
0.7078 | Intermediate Similarity | NPD6410 | Clinical (unspecified phase) |
0.7078 | Intermediate Similarity | NPD1296 | Phase 2 |
0.7063 | Intermediate Similarity | NPD1652 | Phase 2 |
0.7055 | Intermediate Similarity | NPD4661 | Approved |
0.7055 | Intermediate Similarity | NPD4662 | Approved |
0.7052 | Intermediate Similarity | NPD7784 | Clinical (unspecified phase) |
0.7051 | Intermediate Similarity | NPD5124 | Phase 1 |
PubChem CID   | 9817274 |
ChEMBL   | CHEMBL249002 |
ZINC   |
Molecular Weight:   | 284.07 |
ALogP:   | -1.515 |
MLogP:   | 2.67 |
XLogP:   | 1.752 |
# Rotatable Bonds:   | 4 |
Polar Surface Area:   | 86.99 |
# H-Bond Aceptor:   | 1 |
# H-Bond Donor:   | 3 |
# Rings:   | 3 |
# Heavy Atoms:   | 21 |